Ken Griffin’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-130,884
| Closed | -$2.11M | – | 6951 |
|
|
2025
Q1 | $2.11M | Sell |
130,884
-948,423
| -88% | -$15.3M | ﹤0.01% | 2546 |
|
|
2024
Q4 | $25.1M | Buy |
1,079,307
+371,721
| +53% | +$8.65M | ﹤0.01% | 823 |
|
|
2024
Q3 | $20.8M | Hold |
707,586
| – | – | ﹤0.01% | 842 |
|
|
2024
Q2 | $16.6M | Sell |
707,586
-4
| -0% | -$94 | ﹤0.01% | 955 |
|
|
2024
Q1 | $26.8M | Buy |
707,590
+130,879
| +23% | +$4.96M | 0.01% | 756 |
|
|
2023
Q4 | $12.4M | Buy |
576,711
+479,658
| +494% | +$10.3M | ﹤0.01% | 1099 |
|
|
2023
Q3 | $1.19M | Buy |
+97,053
| New | +$1.19M | ﹤0.01% | 2882 |
|
|
2023
Q1 | – | Sell |
-619
| Closed | -$6.96K | – | 6549 |
|
|
2022
Q4 | $6.96K | Sell |
619
-1,812
| -75% | -$20.4K | ﹤0.01% | 5737 |
|
|
2022
Q3 | $32K | Sell |
2,431
-6,657
| -73% | -$87.6K | ﹤0.01% | 5432 |
|
|
2022
Q2 | $115K | Buy |
9,088
+6,151
| +209% | +$77.8K | ﹤0.01% | 5235 |
|
|
2022
Q1 | $169K | Buy |
+2,937
| New | +$169K | ﹤0.01% | 5394 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7167 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7058 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7072 |
|
|
2021
Q1 | – | Sell |
-1,349
| Closed | -$265K | – | 6791 |
|
|
2020
Q4 | $265K | Sell |
1,349
-552
| -29% | -$108K | ﹤0.01% | 4320 |
|
|
2020
Q3 | $337K | Buy |
1,901
+775
| +69% | +$137K | ﹤0.01% | 3761 |
|
|
2020
Q2 | $261K | Buy |
1,126
+178
| +19% | +$41.3K | ﹤0.01% | 3903 |
|
|
2020
Q1 | $110K | Buy |
948
+368
| +63% | +$42.7K | ﹤0.01% | 4321 |
|
|
2019
Q4 | $111K | Buy |
+580
| New | +$111K | ﹤0.01% | 4264 |
|
|
2019
Q3 | – | Sell |
-1,189
| Closed | -$203K | – | 5118 |
|
|
2019
Q2 | $203K | Sell |
1,189
-3,579
| -75% | -$611K | ﹤0.01% | 4120 |
|
|
2019
Q1 | $960K | Buy |
+4,768
| New | +$960K | ﹤0.01% | 2862 |
|
|
2016
Q3 | – | Sell |
-514
| Closed | -$62K | – | 4053 |
|
|
2016
Q2 | $62K | Buy |
+514
| New | +$62K | ﹤0.01% | 3030 |
|